Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentphagocytic vesicle

LAMP2 HAVCR1

1.95e-0315792GO:0045335
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

WAC BICD1 GSE1

6.61e-061519317043677
Pubmed

Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci.

NRBP1 HAVCR1

8.46e-05549223505323
GeneFamilyADAM metallopeptidase domain containing|CD molecules

LAMP2 HAVCR1

2.76e-0339442471
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000

HAVCR1 WAC BICD1 COL6A3 C11orf24

2.29e-0598595Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
ToppCellIPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

BICD1 COL6A3 GSE1

6.81e-0619793f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCellhealthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass

HAVCR1 COL6A3

3.32e-041389297f5dc17522462133e582b508ad0ef036e656872
ToppCellkidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LAMP2 WAC

3.66e-041459247a3bb973a508d3097213a2d86ad1ce697af9bae
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 C11orf24

5.20e-0417392ab6d3507301038f944ad59ccd848b5e6eeb76d04
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BICD1 COL6A3

5.26e-04174924da79da7a09ee1e345102c5331675ebcdbe56171
ToppCellmetastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass

COL6A3 C11orf24

5.50e-04178929a3581a0158dfa5a1cc942f8c532afb5e38b272a
ToppCellLAM-Lymphoid-B-cell-2|Lymphoid / Condition, Lineage and Cell class

LAMP2 C11orf24

6.00e-0418692bcfe0bf2f7f745146b74496a4fcfccd869ad7c6f
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HAVCR1 COL6A3

6.20e-04189923169476f98b7385706cb618c9ad64ae83a290ef0
ToppCellfacs-Aorta-Heart-18m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.33e-04191926242f83acaf1714e9c1771a832cb67674b19e96d
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 GSE1

6.33e-04191923d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 GSE1

6.33e-04191921caf726bd07fdca389e678fc16304a6ef1790423
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 GSE1

6.39e-04192924022f208eb5db760abd0aac782a25e8ab63efc64
ToppCellfacs-Aorta-Heart-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.39e-04192922c6406bc97c3224099b94a43f2890f057b528fa6
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 GSE1

6.39e-04192929333aba0d04203ccccad78d82bf6359922f810a7
ToppCellfacs-Aorta-Heart-18m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.39e-04192926d4fe7ea278efa4b9d43f8a3c282bc0e0e9abaea
ToppCellfacs-Aorta-Heart-18m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.39e-041929247aed7c8e6f5ce1084821212a04f568319e65fd6
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.46e-0419392316ebdf15f75d88c348f909b643fcd315364ca84
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

COL6A3 GSE1

6.53e-0419492b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCelldroplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.59e-0419592fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2
ToppCellfacs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMP2 COL6A3

6.59e-0419592c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.66e-041969259b5b5a0c123d0423abd19c312514849004b903b
ToppCelldroplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.66e-04196921eb14182ef26e6141f510d397b00bf8a12efda3e
ToppCellfacs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMP2 COL6A3

6.66e-0419692b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster

BICD1 GSE1

6.66e-0419692721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster

BICD1 GSE1

6.66e-041969238da0751941adca650fe9b383d9f343153978eb5
ToppCellfacs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMP2 COL6A3

6.66e-0419692787c6cd92035e0b1108c2c086c42a229016e476b
ToppCelldroplet-Heart-HEART-1m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.73e-04197921ec3c05a5d4163df2cf0d168e28a3f1d35364da2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

BICD1 COL6A3

6.73e-041979285a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCellfacs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMP2 COL6A3

6.73e-0419792e77016d64b1cac9825fec7cfe5071f1567401187
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.73e-0419792b16add329bb35a558287ede51353010dde5bc029
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

BICD1 COL6A3

6.73e-0419792e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCellfacs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMP2 COL6A3

6.73e-04197920353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCelldroplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.73e-04197929654472f1d4c9a6caadf1ff61a84902d171e9eb4
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.80e-0419892b086af292a508a156266c2d899ba1caf820bf61c
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HAVCR1 COL6A3

6.80e-0419892b2d295e330772bd8e24da356c75564b4297ea9c5
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.

BICD1 GSE1

6.80e-04198926d12ecaa9532c134d9c4562534dcb59a6420b4d3
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.80e-0419892524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.80e-04198921b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HAVCR1 COL6A3

6.80e-04198923ffaea4b44067d69f954b2bd3119c88a55ab232a
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HAVCR1 COL6A3

6.80e-0419892ce59ee3d970397eb62d6387699c6c6cd65457898
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.

BICD1 GSE1

6.80e-04198927943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.80e-04198925e70246a9ce199cb2fb5379912b8ab59456219e4
ToppCell(2)_B_cell|World / shred on Cell_type and subtype

LAMP2 C11orf24

6.87e-0419992751cfdbc873390bd03837a57367a290f34d53f38
ToppCellCaecum-(2)_B_cell-(20)_B_cell_IgA_Plasma|Caecum / shred on region, Cell_type, and subtype

LAMP2 C11orf24

6.87e-041999276b3c2ee5da8ddc214e5919b5804dfedcbb60d30
ToppCellfacs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.87e-041999267f78c070c56e44fba36542041bf7fa1c291807c
ToppCellCaecum-B_cell|Caecum / Region, Cell class and subclass

LAMP2 C11orf24

6.87e-04199923e4d0206a65643ab12000d7e3af7ddeb2a5f2b62
ToppCellfacs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A3 C11orf24

6.87e-04199921ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCellCaecum-B_cell-B_cell_IgA_Plasma|Caecum / Region, Cell class and subclass

LAMP2 C11orf24

6.87e-041999249c19601566205f41f04bfb5714f865398482d39
ToppCellCaecum-(2)_B_cell|Caecum / shred on region, Cell_type, and subtype

LAMP2 C11orf24

6.87e-041999299c44abd101f9e294468b006a6b7c88c7e6dd020
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type.

BICD1 GSE1

6.93e-04200923d134ae3c48ff4d1849db4fbe44ff73fb6c8c779
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type.

WAC GSE1

6.93e-0420092c92e4fc0442404481fcac623d691dae6215b852d
ToppCellMacroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic

BICD1 GSE1

6.93e-042009288d66550781a3c9102ff7455f5cff6fb072943cd
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BICD1 COL6A3

6.93e-0420092444c72334df421375ae6fc69b0adfd4950d49a43
ToppCellParenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

BICD1 COL6A3

6.93e-04200927642a14855589b0b3f68dbdc9e4d3fc7291854f7
ToppCellCOVID-19|World / group, cell type (main and fine annotations)

LAMP2 COL6A3

6.93e-0420092ac38a468559c33ee00152735ce6e408f3f48df84
ToppCellTCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

ATF7 WAC

6.93e-04200921fa8422fd820d21e285a7e7c4c6fbd8b7277d2af
ToppCellMacroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic

BICD1 GSE1

6.93e-0420092d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

BICD1 COL6A3

6.93e-04200925826c17da67bdaba3a828792279004218d8260c8
ToppCellMacroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic

BICD1 GSE1

6.93e-042009216269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCellMacroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic

BICD1 GSE1

6.93e-042009279634b1086934412ae92f259ab43554ce545008f
ToppCellMacroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic

BICD1 GSE1

6.93e-0420092c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
DrugTiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A

WAC BICD1 GSE1

4.85e-05193931412_DN
DrugAlverine citrate salt [5560-59-8]; Down 200; 8.4uM; HL60; HG-U133A

LAMP2 BICD1 C11orf24

5.24e-05198931426_DN
DrugTolnaftate [2398-96-1]; Up 200; 13uM; HL60; HG-U133A

LAMP2 NRBP1 BICD1

5.31e-05199932001_UP
Drug1h00

LAMP2 COL6A3

2.12e-045692CID000445950
DrugAC1LAKND

LAMP2 COL6A3

2.59e-046292CID000470146
DrugANIT

LAMP2 HAVCR1

3.21e-046992CID000011080
Drug4-hydroxyproline

LAMP2 COL6A3

5.59e-049192CID000000825
DrugDMSe

WAC COL6A3

1.17e-0313292CID000020796
DrugON 01910

LAMP2 GSE1

1.75e-0316292ctd:C507134
DrugHelveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A

HAVCR1 WAC

1.86e-03167926047_UP
Drugkhellin

HAVCR1 COL6A3

1.95e-0317192CID000003828
DrugAC1L1DD6

HAVCR1 COL6A3

2.13e-0317992CID000002299
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

BICD1 GSE1

2.23e-03183922696_DN
DrugPerphenazine [58-39-9]; Up 200; 10uM; PC3; HG-U133A

LAMP2 NRBP1

2.28e-03185921956_UP
DrugHarmine hydrochloride [343-27-1]; Down 200; 16uM; HL60; HG-U133A

NRBP1 C11orf24

2.33e-03187921758_DN
DrugDihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; HL60; HG-U133A

C11orf24 GSE1

2.35e-03188921745_DN
Drug0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.42e-03191926900_DN
Drug17-AAG; Down 200; 1uM; ssMCF7; HG-U133A

LAMP2 C11orf24

2.42e-0319192521_DN
Drugmonastrol; Up 200; 20uM; MCF7; HG-U133A

WAC GSE1

2.42e-0319192614_UP
DrugBeta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A

ATF7 COL6A3

2.45e-03192926050_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A

BICD1 GSE1

2.45e-03192921400_DN
DrugOxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A

BICD1 C11orf24

2.45e-03192921419_DN
DrugCP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.47e-03193923908_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.47e-03193925215_DN
DrugAlbendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A

C11orf24 GSE1

2.50e-03194921547_DN
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; HL60; HG-U133A

WAC C11orf24

2.50e-03194921988_DN
DrugEtofylline [519-37-9]; Down 200; 17.8uM; HL60; HG-U133A

LAMP2 BICD1

2.50e-03194921409_DN
DrugPiroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A

BICD1 GSE1

2.50e-03194921405_DN
DrugChlorhexidine [55-56-1]; Up 200; 8uM; HL60; HG-U133A

LAMP2 BICD1

2.53e-03195922025_UP
Drugwortmannin; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA

BICD1 C11orf24

2.53e-0319592911_DN
DrugButamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.53e-03195926266_DN
DrugPhenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A

ATF7 HAVCR1

2.53e-03195924111_UP
Drugrofecoxib; Up 200; 10uM; MCF7; HG-U133A

BICD1 C11orf24

2.53e-0319592166_UP
DrugBambuterol hydrochloride [81732-46-9]; Down 200; 10uM; HL60; HG-U133A

LAMP2 C11orf24

2.53e-03195921582_DN
DrugSTOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A

WAC C11orf24

2.53e-03195926906_DN
DrugKhellin [82-02-0]; Down 200; 15.4uM; PC3; HG-U133A

LAMP2 GSE1

2.53e-03195921922_DN
DrugFlufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A

NRBP1 BICD1

2.53e-03195921420_DN
Drug1,5-Isoquinolinediol; Down 200; 100uM; HL60; HG-U133A

LAMP2 C11orf24

2.53e-0319592543_DN
DrugMeclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; HL60; HG-U133A

BICD1 GSE1

2.55e-03196921445_DN
DrugEthosuximide [77-67-8]; Down 200; 28.4uM; HL60; HG-U133A

LAMP2 C11orf24

2.55e-03196921433_DN
Drugpioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A

WAC C11orf24

2.55e-03196927083_DN
Drugretinoic acid; Up 200; 1uM; MCF7; HG-U133A

BICD1 COL6A3

2.55e-0319692384_UP
DrugGuanabenz acetate [23256-50-0]; Up 200; 13.8uM; HL60; HG-U133A

LAMP2 BICD1

2.55e-03196922045_UP
DrugIndapamide [26807-65-8]; Up 200; 10.6uM; PC3; HT_HG-U133A

ATF7 BICD1

2.55e-03196924335_UP
DrugCiprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HG-U133A

NRBP1 WAC

2.55e-03196921939_DN
Drug0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.55e-03196926902_DN
DrugPiperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.55e-03196926772_DN
DrugBudesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

WAC GSE1

2.55e-03196926330_DN
DrugNorcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A

WAC BICD1

2.55e-03196924776_DN
Drugraloxifene hydrochloride; Up 200; 0.1uM; HL60; HG-U133A

BICD1 C11orf24

2.58e-0319792388_UP
DrugAcetopromazine maleate salt [3598-37-6]; Down 200; 9uM; HL60; HG-U133A

LAMP2 C11orf24

2.58e-03197921777_DN
DrugMesoridazine besylate [32672-69-8]; Down 200; 7.4uM; HL60; HG-U133A

BICD1 C11orf24

2.58e-03197921725_DN
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.58e-03197923515_DN
Drugestradiol, USP; Up 200; 0.01uM; HL60; HG-U133A

BICD1 C11orf24

2.58e-0319792387_UP
DrugPirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; HL60; HG-U133A

NRBP1 GSE1

2.58e-03197921388_DN
Drugsulindac sulfone; Up 200; 50uM; MCF7; HG-U133A

BICD1 COL6A3

2.58e-0319792314_UP
DrugDydrogesterone [152-62-5]; Up 200; 12.8uM; PC3; HT_HG-U133A

HAVCR1 BICD1

2.58e-03197924254_UP
DrugFusaric acid [536-69-6]; Down 200; 22.4uM; HL60; HT_HG-U133A

NRBP1 BICD1

2.58e-03197921308_DN
DrugDiazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A

C11orf24 GSE1

2.58e-03197925810_DN
DrugPentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A

BICD1 C11orf24

2.58e-03197922343_DN
Drugtetraethylenepentamine pentahydrochloride; Up 200; 100uM; ssMCF7; HG-U133A

ATF7 BICD1

2.58e-0319792498_UP
DrugPyrimethamine [58-14-0]; Down 200; 16uM; PC3; HG-U133A

NRBP1 GSE1

2.58e-03197921894_DN
DrugNicergoline; Down 200; 8.2uM; HL60; HG-U133A

LAMP2 GSE1

2.58e-03197921374_DN
Drug(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.60e-03198925533_DN
Drugrofecoxib; Down 200; 10uM; MCF7; HG-U133A

LAMP2 BICD1

2.60e-0319892251_DN
DrugBupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; HL60; HG-U133A

LAMP2 C11orf24

2.60e-03198921564_DN
DrugZaprinast [37762-06-4]; Up 200; 14.8uM; HL60; HG-U133A

LAMP2 GSE1

2.60e-03198921611_UP
DrugParomomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A

WAC BICD1

2.60e-03198923356_DN
DrugW-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A

ATF7 BICD1

2.60e-0319892440_DN
DrugDacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.60e-03198926816_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HG-U133A

WAC GSE1

2.60e-03198921893_DN
DrugRilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.60e-03198925532_DN
DrugStreptomycin sulfate [3810-74-0]; Down 200; 2.8uM; PC3; HT_HG-U133A

NRBP1 C11orf24

2.60e-03198925837_DN
DrugCortisone [53-06-5]; Up 200; 11uM; HL60; HT_HG-U133A

ATF7 BICD1

2.60e-03198922385_UP
DrugBupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A

NRBP1 BICD1

2.63e-03199922404_DN
Drughaloperidol; Down 200; 10uM; MCF7; HG-U133A

LAMP2 BICD1

2.63e-0319992418_DN
DrugTTNPB; Down 200; 0.1uM; MCF7; HG-U133A

ATF7 BICD1

2.63e-0319992223_DN
DrugIsopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A

BICD1 C11orf24

2.63e-03199925879_DN
DrugPalmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A

ATF7 COL6A3

2.63e-03199924957_UP
Drugaspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A

ATF7 BICD1

2.63e-03199926164_UP
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; HL60; HG-U133A

LAMP2 NRBP1

2.63e-03199921442_DN
DrugGuanethidine sulfate [60-02-6]; Down 200; 13.4uM; HL60; HG-U133A

LAMP2 C11orf24

2.63e-03199921554_DN
DrugStachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A

LAMP2 NRBP1

2.63e-03199921751_DN
DrugEvoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A

BICD1 GSE1

2.63e-03199927380_DN
DrugEpirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A

ATF7 HAVCR1

2.63e-03199925995_UP
DrugEserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; HL60; HG-U133A

C11orf24 GSE1

2.63e-03199921776_DN
DrugMinocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A

BICD1 C11orf24

2.63e-03199925496_DN
DrugVinpocetine [42971-09-5]; Down 200; 11.4uM; HL60; HG-U133A

LAMP2 GSE1

2.63e-03199921557_DN
Diseasesphingomyelin measurement

NRBP1 HAVCR1

3.05e-0327892EFO_0010118
Diseasemyocardial infarction

HAVCR1 COL6A3

4.78e-0335092EFO_0000612
Diseasebasophil count

ATF7 GSE1

8.92e-0348392EFO_0005090

Protein segments in the cluster

PeptideGeneStartEntry
EPSPTKTPTISPVIT

BICD1

591

Q96G01
SVPSTPPVVTIAPTK

GSE1

116

Q14687
VTPKPVLISTPTPTI

ATF7

136

P17544
PPVPTVSLTSVIKSP

KIAA2026

1996

Q5HYC2
IHTTVPSPTTTPTPK

LAMP2

201

P13473
TSPVVPPSVKTPTPE

NRBP1

421

Q9UHY1
PVTTTKPVTTTTKPV

COL6A3

2876

P12111
PPKVTTTPIVTTVPT

HAVCR1

126

Q96D42
TPPVSSQPKVSTPVV

WAC

471

Q9BTA9
TPEPAPTPTVVTTTK

C11orf24

281

Q96F05